Glenview Trust Co Buys New Stake in Danaher Corporation $DHR

Glenview Trust Co bought a new position in Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 18,371 shares of the conglomerate’s stock, valued at approximately $13,228,000.

A number of other hedge funds also recently bought and sold shares of DHR. High Note Wealth LLC boosted its stake in Danaher by 19.2% during the 4th quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock valued at $67,000 after purchasing an additional 47 shares during the period. First Command Advisory Services Inc. boosted its position in shares of Danaher by 4.4% in the fourth quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock valued at $253,000 after acquiring an additional 47 shares during the period. GW&K Investment Management LLC increased its position in Danaher by 8.4% during the fourth quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock worth $138,000 after acquiring an additional 47 shares during the period. Kestra Private Wealth Services LLC raised its stake in Danaher by 0.3% during the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock valued at $3,057,000 after purchasing an additional 48 shares during the last quarter. Finally, Gabelli Funds LLC boosted its holdings in Danaher by 0.3% in the 4th quarter. Gabelli Funds LLC now owns 18,981 shares of the conglomerate’s stock valued at $4,345,000 after purchasing an additional 50 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on DHR shares. Wells Fargo & Company reduced their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $240.00 target price on shares of Danaher in a research report on Wednesday, July 22nd. Piper Sandler began coverage on shares of Danaher in a research note on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target on the stock. Guggenheim reduced their price objective on shares of Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Finally, Stifel Nicolaus cut their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Price Performance

Shares of Danaher stock opened at $216.41 on Friday. The stock has a market capitalization of $152.13 billion, a price-to-earnings ratio of 38.44, a P/E/G ratio of 2.69 and a beta of 0.78. The firm’s 50-day moving average price is $199.46 and its two-hundred day moving average price is $192.52. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80.

Danaher (NYSE:DHR) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. Danaher’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.77 earnings per share. On average, equities analysts predict that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.